Literature DB >> 26111229

Drug survival for methotrexate in a daily practice cohort of adult patients with severe atopic dermatitis.

K Politiek1, J van der Schaft2, P J Coenraads1, M S de Bruin-Weller2, M L A Schuttelaar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26111229     DOI： 10.1111/bjd.13961

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

1.  TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries.

Authors:  Louise A A Gerbens; Aaron E Boyce; Dmitri Wall; Sebastien Barbarot; Richard J de Booij; Mette Deleuran; Maritza A Middelkamp-Hup; Amanda Roberts; Christian Vestergaard; Stephan Weidinger; Christian J Apfelbacher; Alan D Irvine; Jochen Schmitt; Paula R Williamson; Phyllis I Spuls; Carsten Flohr
Journal:  Trials       Date:  2017-02-27       Impact factor: 2.279

Review 2.  Systemic Treatment of Adult Atopic Dermatitis: A Review.

Authors:  Matteo Megna; Maddalena Napolitano; Cataldo Patruno; Alessia Villani; Anna Balato; Giuseppe Monfrecola; Fabio Ayala; Nicola Balato
Journal:  Dermatol Ther (Heidelb)       Date:  2016-12-26

3.  Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry.

Authors:  Lotte S Spekhorst; Lieneke F M Ariëns; Jorien van der Schaft; Daphne S Bakker; Marijke Kamsteeg; Albert J Oosting; Ilona de Ridder; Annemiek Sloeserwij; Geertruida L E Romeijn; Marlies de Graaf; Inge Haeck; Judith L Thijs; Marie L A Schuttelaar; Marjolein S de Bruin-Weller
Journal:  Allergy       Date:  2020-05-05       Impact factor: 13.146

4.  Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort.

Authors:  Stine Elsgaard; Anna Kathrine Danielsen; Jacob P Thyssen; Mette Deleuran; Christian Vestergaard
Journal:  Int J Womens Dermatol       Date:  2021-07-22

5.  Patient Reported Outcome Measure in Atopic Dermatitis Patients Treated with Dupilumab: 52-Weeks Results.

Authors:  Servando E Marron; Lucia Tomas-Aragones; Carlos A Moncin-Torres; Manuel Gomez-Barrera; Francisco Javier Garcia-Latasa de Aranibar
Journal:  Life (Basel)       Date:  2021-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.